Malignant Melanoma
Joint Authors
Carreras Delgado, José Luis
Rodríguez Rey, Cristina
Ortega Candil, Aída
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-12-04
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Nuclear medicine plays an essential role in the correct staging of patients suffering from melanoma.
Both sentinel lymph node biopsy (SLNB) and positron emission tomography (PET) represent its main diagnostic tools.
SLNB is the choice procedure for lymphatic regional staging of these patients, including the result of this technique in the 2002 American Joint Cancer Committee melanoma staging.
SLNB sensitivity is superior than PET/CT for the detection of lymphatic micrometastases in early stages of the disease.
PET/CT is mainly used in confirming clinical metastases suspected, detection of recurrences, and recurrence restaging.
PET/CT has also shown superiority against conventional diagnostic methods in the detection of distant metastases, being able to detect illness even six months earlier than those methods.
American Psychological Association (APA)
Ortega Candil, Aída& Rodríguez Rey, Cristina& Carreras Delgado, José Luis. 2012. Malignant Melanoma. ISRN Dermatology،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-462248
Modern Language Association (MLA)
Ortega Candil, Aída…[et al.]. Malignant Melanoma. ISRN Dermatology No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-462248
American Medical Association (AMA)
Ortega Candil, Aída& Rodríguez Rey, Cristina& Carreras Delgado, José Luis. Malignant Melanoma. ISRN Dermatology. 2012. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-462248
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-462248
